Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata, but identified as Fluidigm Corporation in the filing text) on February 14, 2012. The report discloses the issuance of a press release detailing financial results for the fourth quarter and full year ended December 31, 2011.
Key Financial Metrics
The filing text serves as a notification of the press release (Exhibit 99.1) and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes
The filing does not provide specific details on material changes versus prior periods. It solely references the release of Q4 and full-year 2011 results.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or unusual items. It states that the information furnished under Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference unless expressly stated.
Investor Verification Checklist
- Verify the discrepancy between the metadata company name ("Standard BioTools Inc.") and the registrant name in the filing ("Fluidigm Corporation").
- Review Exhibit 99.1 (the press release) for actual financial figures, as they are not present in the 8-K body text.
- Confirm the specific date of the reported period (ended December 31, 2011) against the filing date (February 14, 2012).
- Note that the financial data in the press release is not automatically incorporated by reference into other SEC filings.